20 Volunteers Suffer Serious Reactions to Johnson & Johnson’s COVID-19 Vaccine
On Sept. 23, 2020, U.S. pharmaceutical and medical devices company Johnson & Johnson, Inc. announced the start of the Phase 3 human clinical trial for its experimental Ad26.COV2.S vaccine for COVID-19. The New Jersey-based company, which is partnering with its subsidiary Janssen Pharmaceutica NV of Belgium on development of the vaccine, is planning to enroll […]
China Administers Unlicensed Experimental COVID-19 Vaccines to Its Citizens
China is the first country in the world to vaccinate its citizens with experimental COVID-19 vaccines that are still undergoing clinical trials. No other country has vaccinated people on such a large scale with experimental COVID-19 vaccines prior to final regulatory approval for general use as China has done with their coronavirus vaccine candidates.1 Chinese […]
Baby Girl Dies in Vietnam Hours After Getting Japanese Encephalitis Vaccine
A 12-month-old baby girl died on Sept. 15, 2020 in Dong Nai, Vietnam hours after receiving a second dose of the Japanese Encephalitis (JE) vaccine at the Hiep Phuoc medical clinic. The child had received a first dose of the vaccine on July 7, 2020.1 2 3 The child became ill shortly after she was […]
WHO: Polio Outbreak in Sudan Caused by Oral Polio Vaccine
The World Health Organization (WHO) recently reported that a new poliovirus outbreak in Sudan is linked to an ongoing string of vaccine strain polio outbreaks in Africa caused by continued use of the live attenuated oral polio vaccine (OPV).1 On Aug. 9, 2020, the Federal Ministry of Health in Sudan notified the WHO of the […]
AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event
News update, Sept. 15, 2020—U.S. regulators paused AstraZeneca’s vaccine trial in the U.S. while the National Institutes of Health (NIH) launches an investigation of its own into a serious side effect in an unnamed patient in Britain. “The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader […]
Novavax’s Adjuvanted COVID-19 Vaccine Caused Severe Adverse Reactions in Clinical Trials
Biotechnology company Novavax, Inc. of Gaithersburg, Maryland recently made public the results of the Phase 1 part of a Phase 1/2 human clinical trial for its experimental NVX-CoV2373 vaccine for COVID-19. According to Novavax, “NVX‑CoV2373 was created using Novavax’s recombinant nanoparticle technology to generate antigen derived from the coronavirus spike (S) protein and contains Novavax’s […]